Member access

4-Traders Homepage  >  Shares  >  Euronext Paris  >  ADOCIA    ADOC   FR0011184241

ADOCIA (ADOC)

261
End-of-day quote. End-of-day quote CHI-X EUROPE LIMITED. - 11/30
0.0000 EUR   0.00%
10/16 ADOCIA : Announces Third-quarter Financial 2014 Results
10/13ADOCIA SAS : quaterly sales release
06/23DJEU Ready to Increase Sanctions on Russia -- Update
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo ADOCIA
Provides research and development services to the biotechnology field

Adocia SA is a biotechnology company that specializes in the development of medicines from already approved therapeutic agents.

It is also engaged in the research and development of biotheraphy products used in tissue regeneration and for treating chronic diseases.

Its products include pipeline, PDGF-BB, BioChaperone insulins combo based on Glargine, BioChaperone ultra-fast analog insulin, HinsBet, monoclonal antibodies formulations, and DriveIn-Dox.

The company was founded by Gérard Soula, OLivier Soula, and Rémi Soula on December 16, 2005 and is headquartered in Lyon, France.


Number of employees : 73 persons.
Sales per Businesses
20122013Delta
EUR (in Million)%EUR (in Million)%
Regenerating Medicine4.00100%5.59100% +28.51%
Sales per Regions
20122013Delta
EUR (in Million)%EUR (in Million)%
France4.00100%5.59100% +28.51%
Managers
NameAgeSinceTitle
Gérard Soula PhD, MBA662005Chairman, President & Chief Executive Officer
Valérie Danaguezian-2006CFO, Principal Financial & Accounting Officer
Olivier Soula PhD, MBA452005Director, Deputy General Manager, Director-R&D
Olivier Martinez PhD, MBA44-Director
Laurent Arthaud52-Director
Dominique Takizawa582011Independent Director
Jérôme Féraud39-Director
Ekaterina Smirnyagina, PhD492013Independent Director
Rémi Soula, PhD-2005Director-Business Development
José Correia, PhD--Director-Preclinical & Clinical Department
Shareholders
NameShares%
BPIFrance Investissement SAS 1,041,84016.8%
Gérard Soula PhD, MBA 898,46314.5%
La Société Hospitalière d'Assurances Mutuelles SA 386,1456.21%
ACG Management SAS 364,7545.87%
Olivier Soula PhD, MBA 317,4905.11%
Rémi Soula, PhD 317,4905.11%
IDInvest Partners SA 309,3204.98%
Oreo Finance SAS 191,3433.08%
Amundi Private Equity Funds SA 88,8781.43%
Gestys SA 48,0000.77%
Holdings
NameShares%Valuation
ADOCIA (ADOC) 40,3260.65%1,912,865 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Surperformance© rating
Overall rating
Trading Rating -
Investor Rating -
Growth (Revenue) -
Valuation -
Finances -
Profitability -
Earnings quality -
Business Predictability -
PER -
Potential -
Yield -
Consensus -
7 days EPS revision -
4 months EPS revision -
1 year EPS revision -
4 months Revenue revision -
1 year Revenue revision -
More Ratings
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
ACTELION LTD
SHANGHAI RAAS BLO..
-
MEDIVATION INC
INTERCEPT PHARMAC..
HUALAN BIOLOGICAL..
BEIJING SL PHARMA..
NPS PHARMACEUTICA..
AGIOS PHARMACEUTI..
TONGHUA DONGBAO P..
RECEPTOS INC
AVANIR PHARMACEUT..
MANNKIND CORPORAT..
GENMAB A/S
CLOVIS ONCOLOGY I..
DYAX CORP.
KERYX BIOPHARMACE..
ACORDA THERAPEUTI..
CHINA BIOLOGIC PR..
BIOCON LTD
INSYS THERAPEUTIC..
Sector Biotechnology & Medical Research
Company contact information
115 avenue Lacassagne
FR-69003 Lyon
France

Phone : +33 (0)4 72 610 610
Fax : +33 (0)4 72 36 39 67
Internet : http://www.adocia.com
Markets and indexes
- PEA / SRD eligible : YES / NO
- NYSE Euronext Paris
- Compartiment C
- CAC All Shares / CAC All-Tradable, CAC Mid Small, CAC PME, CAC Small
Stock Exchange Codes
- ISIN Code :  FR0011184241
- Bloomberg Code :  ADOC:FP
- Reuters Code :  ADOC.PA
- Datastream Code :  
© 2014 Factset    © 2014 Cofisem   
Dynamic quotes  
ON
| OFF